loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Alpress LP

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Synthokem Prazosin Hydrochloride

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Alpress LP

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 719Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurobindo's Generic Prazosin Hydrochloride Receives Approval in the U.S.
    Aurobindo's Generic Prazosin Hydrochloride Receives Approval in the U.S.

    31 Mar 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213052

    FDA
    31 Mar 2023
    Share Share
    Alembic Pharmaceuticals gets USFDA nod for hypertension drug
    Alembic Pharmaceuticals gets USFDA nod for hypertension drug

    08 Mar 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharmaceuticals-gets-usfda-nod-for-hypertension-drug/articleshow/98495957.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    08 Mar 2023
    Share Share
    Mankind's Generic Prazosin Hydrochloride Receives Approval in the U.S.
    Mankind's Generic Prazosin Hydrochloride Receives Approval in the U.S.

    30 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215697

    FDA
    30 Dec 2022
    Share Share
    Appco's Generic Prazosin Hydrochloride Receives Approval in the U.S.
    Appco's Generic Prazosin Hydrochloride Receives Approval in the U.S.

    21 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213406

    FDA
    21 Oct 2022
    Share Share
    ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules
    ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules

    01 Feb 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210201005277/en

    BUSINESSWIRE
    01 Feb 2021
    Share Share
    ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules
    ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules

    01 Feb 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210201005277/en/ANI-Pharmaceuticals-Announces-Launch-of-Prazosin-Hydrochloride-%E2%80%9CHCl%E2%80%9D-Capsules

    BUSINESSWIRE
    01 Feb 2021
    Share Share